MissFrancine Heatley
Clinical Trials Manager
Department of Surgery & Cancer - Faculty of Medicine
Orcid identifier0000-0002-5184-0259 (opens in a new tab)
- Clinical Trials ManagerDepartment of Surgery & Cancer - Faculty of Medicine
- 020 3311 7371 (Work)
- 3.00E+04, East Wing, Charing Cross Campus, United Kingdom
BIO
Dr Francine Heatley is a Trial Manager in the Section of Vascular Surgery (Surgery and Cancer) within the Faculty of Medicine at Imperial College.
Francine is a Biology graduate from the University of Nottingham with 20 years experience of conducting clinical research in therapeutic areas such as vascular surgery, cardiovascular and oncology . She spent 3 years working for an academic research organisation in Canada and is familiar in both Health Canada and FDA clinical trial regulations.
At Imperial, she currently manages the NIHR funded GRACE study which is evaluating the potential benefit of Graduated Compression Stockings (GCS) in addition to extended duration pharmacological thromboprophylaxis (EDPTP) for surgical patients at highest risk of venous thromboembolism (VTE). Previously, she has managed the NIHR funded VEIN platform development grant submission, the NIHR DM-PAD study investigating the best diagnostic test for the detection of peripheral arterial disease in patients with diabetes, the JP Moulton funded DAVE (Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration) Trial and the NIHR EVRA (Early Venous Reflux Ablation) ulcer trial: A randomised clinical trial to compare early versus delayed endovenous treatment of superficial venous reflux in patients with chronic venous ulceration. The study results were published in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/nejmoa1801214
Francine completed her PhD in Leg Ulcer outcomes at Imperial College London in June 2021.
Francine is a Biology graduate from the University of Nottingham with 20 years experience of conducting clinical research in therapeutic areas such as vascular surgery, cardiovascular and oncology . She spent 3 years working for an academic research organisation in Canada and is familiar in both Health Canada and FDA clinical trial regulations.
At Imperial, she currently manages the NIHR funded GRACE study which is evaluating the potential benefit of Graduated Compression Stockings (GCS) in addition to extended duration pharmacological thromboprophylaxis (EDPTP) for surgical patients at highest risk of venous thromboembolism (VTE). Previously, she has managed the NIHR funded VEIN platform development grant submission, the NIHR DM-PAD study investigating the best diagnostic test for the detection of peripheral arterial disease in patients with diabetes, the JP Moulton funded DAVE (Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration) Trial and the NIHR EVRA (Early Venous Reflux Ablation) ulcer trial: A randomised clinical trial to compare early versus delayed endovenous treatment of superficial venous reflux in patients with chronic venous ulceration. The study results were published in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/nejmoa1801214
Francine completed her PhD in Leg Ulcer outcomes at Imperial College London in June 2021.
FACULTY
- Faculty of Medicine
POSITION NAME
- Clinical Trials Manager